Pharmacophore
Quantum–Classical Drug Discovery after the Advantage Claim: Matching Computational Methods to Problems They Can Credibly Solve
David Thompson, Sarah Mitchell, Rachel Adams, James Brown
Abstract
Quantum computing has become increasingly visible in pharmaceutical research, yet the evidentiary meaning of an “advantage” claim remains unsettled. Drug discovery contains heterogeneous scientific decisions, data structures, computational abstractions, validation standards, and translational consequences. Consequently, improvement in circuit execution, molecular-energy estimation, sampling, classification, or candidate generation cannot by itself establish pharmaceutical usefulness. This Origin